Quick Takeaways
- Cowen Financial Products LLC filed SCHEDULE 13G/A for Exagen Inc. Common Stock, par value $0.001 per share (XGN).
- Disclosed ownership: 5%.
- Date of event: 31 Mar 2025.
Cowen Financial Products LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Exagen Inc. Common Stock, par value $0.001 per share (XGN)
- Filing Manager
- Cowen Financial Products LLC
- Reporting Manager
- Cowen Financial Products LLC
- Symbol
- XGN
- Shares outstanding
- 17,827,320 shares
- Disclosed Ownership
- 891,366 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 May 2025, 17:37:35 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Cowen Financial Products LLC disclosed 5% ownership in Exagen Inc. Common Stock, par value $0.001 per share (XGN) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 May 2025, 17:37.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Cowen Financial Products LLC | 5% | 891,366 | 891,366 | 0 | John Holmes | Chief Operating Officer |